Search results
McDermottPlus Check-Up: June 21, 2024
The National Law Review· 2 days agoThe hearing discussed ways to improve work incentives for those on social security disability benefits. Senate Finance Committee Chair Releases Draft...
Medicare Advantage Star Ratings proposal targets top performers
Modern Healthcare· 6 days agoAt issue is what's known as the "hold harmless" policy. Medicare Advantage contracts that earn at least 4 out of 5 stars can choose to disregard two highly weighted “quality ...
Insured patients often save less with Mark Cuban's drug company: Study
Becker’s Hospital Review· 6 days agoIndividuals with health insurance are more likely to spend less on generic drugs when using their benefits compared to going through Mark Cuban's Cost Plus Drug Company, according to a study ...
Kirsten Axelsen: Affordable access to weight loss drugs needed (Opinion)
The Charleston Gazette· 4 days agoSen. Bernie Sanders, I-Vt., is getting a piece of the attention being paid to weight loss drugs. Unsurprisingly, these medicines have gotten a lot of notice; losing weight and keeping it off ...
Final Section 1557 Rules: Highlights for Health Plan Sponsors | JD Supra
JD Supra· 4 days agoThe new rules apply to certain group health plans, as well as many health care providers. The nondiscrimination rules apply to employer-sponsored group health plans that receive funding from ...
Congress OKs Israel F-15 sale as Biden takes heat on heavy bomb pause
Federal Times· 5 days agoThe White House has convinced two key Democrats on Capitol Hill to lift their hold on a roughly $18 billion F-15 sale to Israel, even as Israeli Prime Minister Benjamin Netanyahu adds to pressure ...
Gateway - Quartz
Quartz· 6 days agoCenters for Medicare and Medicaid Services (CMS) announced on Thursday. “CMS has issued guidance to Medicare Part D
The Rev. Jeffrey Jackson: Cover anti-obesity drugs for older people in Wisconsin
Wisconsin State Journal· 13 hours agoAs a Middleton alderman and reverend, one of the issues I hear most from my neighbors and...
How Eli Lilly is managing soaring demand for GLP-1s, according to outgoing CFO Anat Ashkenazi
CNBC· 7 days agoSkyrocketing demand for a class of weight loss and diabetes treatments has lifted Eli Lilly to new...
Gateway - Quartz
Quartz· 6 days agoAfter dominating the market for weight loss drugs, Ozempic maker Novo Nordisk has set its sights on tackling treatments for heart disease next. Cardior, a Germany-based drug maker, develops ...
